NEW YORK (GenomeWeb News) — Johnson & Johnson subsidiary Veridex said Tuesday that the US Food and Drug Administration has cleared its RT-PCR breast cancer assay that detects the spread of breast cancer in the lymph nodes.
 
Detecting breast cancer in the lymph nodes may offer faster and more accurate diagnoses of the spread of the disease, thereby potentially reducing the need for additional surgeries, Veridex said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.